Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3187 |
|
| Actual shortage: | 257 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2919 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT REPAGLINIDE | 2MG | TABLET | Actual shortage | 2021-11-18 | 2021-11-18 | 149606 |
| ACT RIZATRIPTAN | 10MG | TABLET | Resolved | 2017-05-24 | 2017-09-19 | 10988 |
| ACT RIZATRIPTAN | 10MG | TABLET | Resolved | 2019-09-05 | 2019-10-17 | 93169 |
| ACT RIZATRIPTAN | 10MG | TABLET | Resolved | 2020-05-29 | 2020-06-04 | 116135 |
| ACT RIZATRIPTAN | 10MG | TABLET | Resolved | 2024-05-09 | 2025-04-28 | 227492 |
| ACT RIZATRIPTAN | 10MG | TABLET | Resolved | 2024-07-04 | 2025-04-28 | 232235 |
| TEVA-ROPINIROLE | 0.25MG | TABLET | Resolved | 2019-10-17 | 2020-04-02 | 96714 |
| TEVA-ROPINIROLE | 1MG | TABLET | Resolved | 2020-01-30 | 2020-06-11 | 104908 |
| TEVA-ROPINIROLE | 0.25MG | TABLET | Resolved | 2020-05-01 | 2020-08-17 | 113779 |
| ACT SUMATRIPTAN | 100MG | TABLET | Resolved | 2019-08-29 | 2020-07-10 | 92684 |
| TEVA-TEMOZOLOMIDE | 5MG | CAPSULE | Resolved | 2019-10-31 | 2020-07-09 | 97584 |
| TEVA-TEMOZOLOMIDE | 20MG | CAPSULE | Resolved | 2020-01-30 | 2020-07-09 | 104922 |
| TEVA-TEMOZOLOMIDE | 250MG | CAPSULE | Resolved | 2020-01-30 | 2020-06-18 | 104927 |
| TEVA-TEMOZOLOMIDE | 100MG | CAPSULE | Resolved | 2020-08-27 | 2020-09-10 | 123093 |
| TEVA-TEMOZOLOMIDE | 100MG | CAPSULE | Resolved | 2020-09-10 | 2020-11-07 | 124085 |
| TEVA-TEMOZOLOMIDE | 250MG | CAPSULE | Resolved | 2020-09-25 | 2020-11-07 | 125028 |
| TEVA-TEMOZOLOMIDE | 20MG | CAPSULE | Resolved | 2020-10-01 | 2020-11-07 | 125512 |
| TEVA-TEMOZOLOMIDE | 5MG | CAPSULE | Resolved | 2021-01-22 | 2021-06-03 | 132279 |
| TEVA-TEMOZOLOMIDE | 250MG | CAPSULE | Resolved | 2021-09-30 | 2021-10-21 | 146434 |
| TEVA-TERBINAFINE | 250MG | TABLET | Resolved | 2020-04-10 | 2023-10-03 | 111874 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |